Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy.

Huff, Mallorie L; Kalter, Joshua A; Chase, Ramona E; Gupta, Ranju

Huff, Mallorie L; Kalter, Joshua A; Chase, Ramona E; Gupta, Ranju.

Afiliación

Huff ML; Division of Hematology and Medical Oncology, Morsani College of Medicine, University of South Florida, Tampa, USA.
Kalter JA; Division of Hematology and Medical Oncology, Lehigh Valley Health Network, Allentown, USA.
Chase RE; Division of Hematology and Medical Oncology, Morsani College of Medicine, University of South Florida, Tampa, USA.
Gupta R; Division of Hematology and Medical Oncology, Lehigh Valley Health Network, Allentown, USA.

Cureus ; 14(1): e21748, 2022 Jan.

Article en En | MEDLINE | ID: mdl-35251819

Palabras clave

her-2 positive breast cancer; her-2-neu; herceptin; perjeta; pertuzumab; thrombocytopenia; trastuzumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cureus Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google